Same-Arm Vaccine Booster Enhances Early Immune Response, Study Finds

A recent study led by Sydney’s Garvan Institute of Medical Research and the Kirby Institute at UNSW Sydney, published in Cell, reveals that receiving a booster vaccine in the same arm as the initial dose accelerates the immune system’s ability to generate protective antibodies. The research highlights the role of lymph nodes and macrophages in optimizing vaccine effectiveness.

When a vaccine is administered, macrophages in lymph nodes near the injection site become “primed” to coordinate memory B cells, which are critical for rapid antibody production upon re-exposure to a pathogen. Using advanced imaging techniques, researchers observed that memory B cells migrate to the outer layers of local lymph nodes, where they interact with macrophages. A booster delivered to the same arm leverages these pre-activated macrophages, which efficiently capture the vaccine antigen and trigger memory B cells to produce high-quality antibodies.

The findings, validated in both mice and human participants, demonstrate practical implications for vaccination strategies. In a clinical trial with 30 Pfizer-BioNTech COVID-19 vaccine recipients, those who received boosters in the same arm as their first dose developed neutralizing antibodies against SARS-CoV-2 within the first week-significantly faster than the opposite-arm group. These early antibodies also showed improved effectiveness against Delta and Omicron variants. While antibody levels equalized by four weeks, the accelerated response could enhance outbreak containment by providing earlier population-level protection.

“This is a fundamental discovery in how the immune system organises itself to respond better to external threats-nature has come up with this brilliant system and we’re just now beginning to understand it,” says Tri Phan, co-senior author. The study emphasizes that while differing injection sites ultimately yield comparable protection, same-arm administration may optimize early immunity during pandemics.

The team suggested these insights could inform future vaccine design, potentially reducing the need for frequent boosters. “If we can understand how to replicate or enhance the interactions between memory B cells and these macrophages, we may be able to design next-generation vaccines that require fewer boosters,” adds Professor Phan.